About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, May 19th, 2015

The QualityStocks
Daily Stock List


Nephros, Inc. (NEPH)

Greenbackers reported last week on Nephros, Inc. (NEPH), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1997, Nephros, Inc. is a commercial stage medical device company listed on the OTC Bulletin Board. The Company develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a hemodialysis machine for the treatment of patients with end stage renal disease. Nephros has its corporate headquarters in River Edge, New Jersey.

Healthcare professionals affiliated with Columbia University Medical Center/New York-Presbyterian Hospital founded Nephros to develop and commercialize a hemodiafiltration system, an alternative method to hemodialysis (HD). Nephros has extended its filtration technologies to meet the demand for liquid purification in other areas, in particular water purification. Its filters, named ultrafilters, are chiefly employed in dialysis centers and hospitals for the removal of biological contaminants from water, bicarbonate concentrate, and/or blood.

Nephros filters use a proprietary hollow fiber technology. The hollow fiber design enables the filters to optimize filtration – as low as 5 nanometers; flow rate – minimal disruption; and also filter life – up to 12 months. The Company has greater than 100 patents issued worldwide based on 15 different inventions.

These are primarily geared around its expertise as a filter development enterprise, specializing in hollow fiber ultrafiltration membrane technology. Nephros provides ultrafilters for sale to customers in the Dialysis Centers - Water/Bicarbonate; Dialysis Centers – Blood; Military and Outdoor Recreation, and Commercial Facilities including Hospitals markets.

Essentially, Nephros has developed its alternative to current hemodialysis therapy known as Mid-dilution hemodiafiltration (mid-HDF). The Company’s proprietary blood purification technologies enable mid-HDF to be offered to chronic renal failure patients.

Last Friday, Nephros announced financial results for the three months ended March 31, 2015. Total revenue for the quarter ended March 31, 2015, was approximately $527,000 versus approximately $473,000 for Q1 2014. Revenue from product sales increased 140 percent. Revenue from fees and other payments received under its licensing arrangements decreased by approximately $237,000 to $17,000.

Net operating loss for the quarter ended March 31, 2015, was approximately $806,000 versus a loss of approximately $562,000 in Q1 2014. As of March 31, 2015, Nephros had cash and cash equivalents of around $367,000.

Nephros, Inc. (NEPH), closed Tuesday's trading session at $0.7799, down 0.01%, on 2,950 volume with 4 trades. The average volume for the last 60 days is 9,536 and the stock's 52-week low/high is $0.4902/$1.29.

Mikros Systems Corp. (MKRS)

Fast Money Alerts, PricelessPennyStocks, Actual Gains, PennyStockRumors.net, and AddictivePennyStocks reported earlier on Mikros Systems Corp. (MKRS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 1978, Mikros Systems Corp. is an advanced technology company headquartered in Princeton, New Jersey. The Company designs and manufactures specialized electronic systems for the Department of Defense. Its primary business is to pursue and obtain contracts from the Department of Homeland Security, the U.S. Navy, and other governmental authorities. Mikros Systems’ shares trade on the OTC Markets Groups OTCQB.

The Company’s capabilities include technology management, electronic systems engineering and integration, radar systems engineering, command, control, communications, computers and intelligence systems engineering, and communications engineering. Mikros has developed, delivered, as well as installed military-grade equipment to Federal customers for more than three decades.

Mikros Systems has required processes in place for the handling, accounting, storage and control of classified material. Most of the Company’s employees are cleared for classified information knowledge. Mikros’ Lifecycle Support capability is focused on ensuring the systematic interactions between Integrated Logistics Support (ILS), Depot, and Field Support activities are integrated to attain the highest levels of system readiness.

At the end of March 2015, Mikros Systems announced strong financial results for 2014. This includes record profits for the year and the largest backlog for future orders in its history. The Company reported revenues of $5.53 million in 2014, versus $3.05 million in 2013. This represent an increase of $2.48 million or in excess of 80 percent. Net income was $533,000, versus a loss of $147,000 in 2013. As of December 31, 2014, the backlog for future orders was $5.5 million.

Company highlights for 2014 include a $5 million production contract for 54 additional ADEPT units for the SPY-1 radar used on all Navy cruisers and destroyers. The Adaptive Diagnostic Electronic Portable Testset (ADEPT®) is an intelligent, automated, programmable electronic test tool. The design of it is to aid technical personnel in the maintenance, alignment, calibration, and error diagnosis of radar and other complex electronic systems.

Highlights for 2014 also include six new production support contracts for ADEPT training, maintenance and repair valued at $413,882; and new development programs to upgrade ADEPT capabilities for improved instrumentation and operating system upgrades. Furthermore, 2014 highlights include the first Mikros development program to adapt ADEPT for another Navy radar model - the SPS-49 that is presently installed on more than 100 Navy ships; and continuing development of the new ADSSS condition-based maintenance system for the Littoral Combat Ship, and installation of a pilot ADSSS system on the USS Fort Worth (LCS 3).

Mikros Systems Corp. (MKRS), closed Tuesday's trading session at $0.155, even for the day, on 46,900 volume with 5 trades. The average volume for the last 60 days is 28,281 and the stock's 52-week low/high is $0.11/$0.24.

Validian Corp. (VLDI)

Profit Sensation, Pumps and Dumps, PennyStocks24, and OTC Stock Review reported previously on Validian Corp. (VLDI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Validian Corp. provides software products for public and private enterprises. The Company develops and markets solutions to protect against the threats of today's digital world. It is first-to-market to provide secure storage, access, and transfer of Digital Information on wired, wireless, or mobile networks over the Internet. Its mission is to deliver innovative information protection solutions, which assist government agencies, enterprises, and individuals in lessening the impact of theft, disclosure, non-compliance, or malicious tampering with digital assets. The Company lists on the OTC Markets Group’s OTCQB.

Validian offers solutions that can undergo customization to the client's business process to ensure end-to-end authenticity, integrity, and also custody of high value digital assets. The Company’s technology enables the next generation of secure Cloud Computing, Cloud Storage, Distributed Computing and Web Application and WebPortal Access and Usage for desktop and laptop computers, servers, tablets, and SmartPhones.

The Company’s products include ValidianProtect, which embeds its technology into any application. Another product is Validian Media Protect. This is an anti-piracy solution. Validian Media Protect safeguards high-value movie and music content during production and post-production.

Validian also has its Validian Medical Protect. This provides secure remote access and exchange of any type of medical file between medical professionals. In addition, its products include Validian Secure Microsoft SharePoint. This allows secure content management and web portals. Products also include Validian Mobile, which enables secure e-commerce transactions over non-compatible Smartphone devices, cell sites, and networks.

This month, Validian announced the extension of its cyber security technology to secure access to servers and data bases and to protect the access, retrieval, transfer, receipt, and storage of digital information on servers, data bases and memory, and also on mobile and non-mobile devices, using wired, wireless and mobile networks. The design of this extension is to prevent hacking and improper access of data on all parts of Information Technology (IT) systems.

Additionally, this month, Validian announced that it successfully demonstrated to several of its Channel Partners the ability of its cyber security technology to secure highly efficient Peer-To-Peer (P2P) communications on mobile and non-mobile devices. Validian indicated that this marks a major step toward securing otherwise insecure but, in numerous cases, highly efficient communications.

Validian Corp. (VLDI), closed Tuesday's trading session at $0.0402, down 1.95%, on 917,064 volume with 46 trades. The average volume for the last 60 days is 514,516 and the stock's 52-week low/high is $0.0212/$0.075.

Sunshine Biopharma, Inc. (SBFM)

Greenbackers, Jet-Life Penny Stocks, Shiznit Stocks, Fast Money Alerts, MassiveStockProfits, Stock Shock and Awe, and Penny Stock General reported earlier on Sunshine Biopharma, Inc. (SBFM), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Sunshine Biopharma, Inc. is a pharmaceutical company focusing on the research, development, and commercialization of drugs for the treatment of various forms of cancer. Its’ dedication is to developing novel therapies for the treatment of different forms of aggressive cancer types. Sunshine Biopharma has its Canadian wholly-owned subsidiary: Sunshine Biopharma Canada, Inc. This subsidiary conducts pharmaceutical business in Canada and elsewhere internationally. Sunshine Biopharma’s shares trade on the OTCQB.

The Company’s first drug candidate, Adva-27a, is a small molecule, which has proven effective against different types of multidrug resistant cancer cell lines. These include breast cancer (MCF-7/MDR), small-cell lung cancer (H69AR), uterine carcinoma (MES-SA/Dx5) as well as pancreatic cancer (Panc-1).

Sunshine Biopharma’s Adva-27a is a GEM-difluorinated C-glycoside derivative of Podophyllotoxin, targeted for different forms of cancer.  Adva-27a is presently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935.

Sunshine Biopharma has an agreement with Lonza, a foremost development and manufacturing company, for the manufacture of its anti-cancer drug, Adva-27a. Lonza has expertise and experience in small molecule development and manufacturing of active pharmaceutical ingredients. Manufacturing will be at Lonza's Nansha, China facility. The remaining important steps will take place in Lonza's high containment cytotoxic facility in Visp, Switzerland.

The Company entered into a collaboration agreement in January of 2011 with Binghamton University (State University of New York at Binghamton, New York). This agreement is to conduct certain research and development activities intended at advancing Sunshine Biopharma’s lead compound, Adva-27a, through different stages of preclinical development.

Sunshine Biopharma entered into a Clinical Trials Agreement in June of 2011 with The Jewish General Hospital, one of McGill University’s Hospital Centers, to conduct certain R&D activities and advance its Adva-27a through the various stages of preclinical studies and Phase I clinical trials on multidrug resistant breast cancer patients. The Company is planning a Phase I clinical trial of Adva-27a for pancreatic cancer in parallel to the Phase I clinical trial of Adva-27a for multidrug resistant breast cancer to be conducted at McGill University's Jewish General Hospital in Montreal.

Recently, Sunshine Biopharma announced that a "Notice of Allowance" for the patent application covering the Company’s lead antitumor compound, Adva-27a, was recently issued in India. The allowed claims in India are almost identical to those already issued in the U.S. (US Patent Number 8,236,935) where Sunshine Biopharma is the exclusive licensee. Adva-27a patents are also issued in Canada and Europe.

Sunshine Biopharma, Inc. (SBFM), closed Tuesday's trading session at $0.03, even for the day, on 2,100 volume with 2 trades. The average volume for the last 60 days is 821,611 and the stock's 52-week low/high is $0.0121/$0.18.

Genius Brands International, Inc. (GNUS)

RedChip, PennyStocks24, and Barchart reported on Genius Brands International, Inc. (GNUS), and today we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Genius Brands International, Inc. is a global brand management company that lists on the OTC Markets’ OTCQB. The Beverly Hills, California-based Company creates and licenses multimedia content for toddlers to tweens. Genius Brands creates "content with a purpose". This means content that is as entertaining as it is enriching. A Squared Entertainment is a wholly-owned subsidiary of Genius Brands International.

Genius Brands International’s growing library of content includes the award-winning Baby Genius, Warren Buffett's Secret Millionaires Club, Thomas Edison's Secret Lab, and Llama Llama, from the NY Times bestselling children's book franchise, and Stan Lee's Mighty 7, the first project from Stan Lee Comics, a joint venture with Stan Lee's POW! Entertainment.

Genius Brands’ A Squared Entertainment is a brand management and licensing company. It represents third-party properties across a wide spectrum of categories in territories globally. A Squared Entertainment presently represents Psycho Bunny, a luxury apparel line; From Frank, a humor greeting card and product line; and Celessence Technologies, the world's foremost microencapsulation company.

In early May, Genius Brands International announced that it licensed its original animated series Thomas Edison's Secret Lab to the premiere broadcast channel Da Vinci Learning for airing in Russia, Central and Eastern Europe, Turkey, and Africa. An academic team headed by Professor Emeritus, Don Roberts, and a team of Emmy Award winning writers developed Thomas Edison's Secret Lab. This ensures it’s E/I (Educational/Informational) compliant per FCC standards. Thomas Edison's Secret Lab is a fully immersive multimedia property. It encourages children to engage themselves in the fun and exploration of science.

Last week, Genius Brands International announced that it awarded Wicked Cool Toys the exclusive worldwide rights to develop and market a wide-ranging line of toys based on Genius Brands' original animated adventure series, Thomas Edison's Secret Lab. This is the above-mentioned new comedy that shows kids how much fun science can be.

Wicked Cool will develop and bring to market an appealing line of STEM-based toys. These include compounds, activity kits, science kits, food sets, figures, play sets, novelties and role play products. These products encourage children to explore and have fun with science, inspired by Thomas Edison's inventive spirit.

Genius Brands International, Inc. (GNUS), closed Tuesday's trading session at $2.87, down 5.90%, on 1,700 volume with 4 trades. The average volume for the last 60 days is 3,204 and the stock's 52-week low/high is $1.33/$4.89.


The QualityStocks
Company Corner


IFAN Financial, Inc. (IFAN)

The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.12, up 14.07%, on 108,190 volume with 26 trades. The stock’s average daily volume over the past 60 days is 50,144, and its 52-week low/high is $0.0114/$1.01.

IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.

Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.

Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.

IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer

IFAN Financial, Inc. Company Blog

IFAN Financial, Inc. News:

IFAN Financial Payment Gateway Adopted by Digital Branding Agency Blue Like Neon to Bolster Customers' eCommerce Capabilities

IFAN Financial, Inc. (IFAN) Expands Board of Directors With Addition of Technology Venture Veteran

IFAN Financial Applauds Facebook's Move Into the Mobile Payments Industry, Foresees Ancillary Opportunities

Cleartronic, Inc. (CLRI)

The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.18, up 6.51%, on 26,220 volume with 9 trades. The stock’s average daily volume over the past 60 days is 22,220, and its 52-week low/high is $0.04/$0.5499.

Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.

VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.

A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.

Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer

Cleartronic, Inc. Company Blog

Cleartronic, Inc. News:

Cleartronic, Inc. (CLRI) on the "Your Monies Worth" Show

Cleartronic, Inc. (CLRI) to Be Featured on National Radio Show And Web-TV

Cleartronic, Inc. (CLRI) Breaks 40 Million in Radio Transmissions as Both Customer Base and Transmissions Continue Rapid Growth

Sibling Group Holdings, Inc. (SIBE)

The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.05, off by 4.76%, on 105,800 volume with 8 trades. The stock’s average daily volume over the past 60 days is 77,813, and its 52-week low/high is $0.0423/$0.22.

Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.

Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.

Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.

IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer

Sibling Group Holdings, Inc. Company Blog

Sibling Group Holdings, Inc. News:

Sibling Groups Blended Schools Network Powers Mountain House High Schools Personalized Learning; BSN Curriculum Achieves California A-G Certification

Sibling Group's Urban Planet Mobile Deepens Strategic Partnership With Imagine Easy Solutions and EasyBib; UPMs Writing Planet Essay Scoring Solution to Be Offered Across All Imagine Easy Citation Websites Worldwide

Strategic Partner Shenzhen Times Increases Stake in Sibling Group; $5,500,000 Warrant Exercise to Fund Growth Initiatives

Growblox Sciences, Inc. (GBLX)

The QualityStocks Daily Newsletter would like to spotlight Growblox Sciences, Inc. (GBLX). Today, Growblox Sciences, Inc. closed trading at $0.39005, off by 4.87%, on 79,728 volume with 37 trades. The stock’s average daily volume over the past 60 days is 63,484, and its 52-week low/high is $0.151/$3.49.

Growblox Sciences, Inc. (GBLX), a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

The company’s GrowBLOX technology suite includes the TissueBLOX, GrowBLOX, and CureBLOX equipment. Together, these components provide unparalleled control and monitoring of cannabis cultivation throughout the plant's life-cycle. These patent pending processes were designed to produce a safe and consistent cannabis product under cGMP guidelines. Utilizing a computer-regulated system that optimizes the nutrients, water, temperature, and gas levels, the GrowBLOX suite produces cannabis with more active ingredients per pound than traditional cultivation methods.

Also, based on an analysis of preclinical and clinical data from thousands of peer-reviewed studies, Growblox Sciences has identified the most effective profiles of cannabinoids and terpenes for the treatment of conditions within seven therapeutic categories. As a result of this extensive research and the analysis of the active ingredient profiles of 30,000 Cannabis strains in conjunction with a major testing lab, the company will be able to provide patients with natural cannabis strains containing the ideal ratios for treating specific diseases or symptoms.

Another significant advantage held by the company stems from an accelerated drug development program to finish in 3-5 years instead of the 15-20 years typically seen in traditional pharmaceutical development programs. Armed with an intellectual property strategy that takes full advantage of the design of the GrowBLOX technology suite and protects the valuable foundation laid, Growblox Sciences has positioned itself well for long-term success in the burgeoning cannabis space. Disclaimer

Growblox Sciences, Inc. Company Blog

Growblox Sciences, Inc. News:

Growblox Sciences, Inc. (GBLX) is “One to Watch”

Growblox Announces Commercialization Initiative and Financing

Growblox Sciences Announces Launch of New Corporate Website

Car Monkeys Group (CKMY)

The QualityStocks Daily Newsletter would like to spotlight Car Monkeys Group (CKMY). Today, Car Monkeys Group closed trading at $0.15, even for the day. The stock’s average daily volume over the past 60 days is 8,169, and its 52-week low/high is $0.05/$5.00.

Car Monkeys Group (CKMY), via CarMonkeys.com, is one of the largest and fastest growing online cars, vans and SUV parts distributors in the United States. Founded in 2010, the Wyckoff, New Jersey-based company formerly was known as Delaine Corporation and changed its name to Car Monkeys Group in February 2015.

With access to hundreds of thousands of parts, Car Monkeys sells used, high-quality, low-mileage automotive parts to consumers, retailers, truck and car fleet owners and auto repair facilities looking for a wide range of vehicle makes and models. Customers have access to a Part Finder section that helps them easily navigate and quickly locate the right parts they need.

Striving to provide customers a quick, hassle-free and convenient shopping experience, all parts ordered through CarMonkeys.com ship from one of the company’s numerous distributors and auto dismantling centers straight to the customer or their mechanic. Advantages such as a five-year unlimited mileage warranty, zero shipping costs, and a generous return policy further contribute to the increasing popularity of the Car Monkeys brand.

Automotive recycling plays a substantial role in the preservation of natural resources and reduction of demand for landfill space. According to the Automotive Recyclers Association, approximately 95% of vehicles retired from use are processed for recycling, saving an estimated 85 million barrels of oil that would have been used to manufacture new or replacement parts. As a rapidly growing and trusted automotive recycling company, Car Monkeys is positioned as a leading player in the broader $22 billion North American automotive recycling industry. Disclaimer

Car Monkeys Group Company Blog

Car Monkeys Group News:

Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services

Car Monkeys Group (CKMY) is “One to Watch”

Car Monkeys Group (CKMY) Continues Growth as one of the Country’s Largest Online Automobile Parts Distributors


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Gryphon Digest



By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251